15
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis

, , , &
Pages 95-101 | Received 03 Aug 1998, Accepted 09 Sep 1998, Published online: 10 Jul 2009

References

  • Asensio V C, Campbell I L. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol 1997; 71: 7832–7840
  • Billiau A, Heremans H, Vandekerckhove F, Dijkmans R, Sobis H, Meulepas E, Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 1988; 140: 1506–1510
  • Cheifetz S, Moscarello M, Deber C. NMR investigation of the charge isomers of bovine myelin basic protein. Arch Biochem Biophys 1984; 233: 151–160
  • Dalton D, Pitts-Meek S, Keshav S, Figari I, Bradley A.TA S. Multiple defects of immune cell function in mice with disrupted interferon-gamma gene. Science 1993; 259: 1739–1742
  • Duong T, Finkelman F, Singh B, Strejan G. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J Neu-roimmunol 1994; 53: 101–107
  • Ferber I, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman C. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis. J Immunol 1996; 156: 5–7
  • Glabinski A, Tani M, Aras S, Stoler M, Tuohy V, Ransohoff R. Regulation and function of central nervous system chemokines. International J Dev Neurosci 1995a; 13: 153–165
  • Glabinski A, Tani M, Tuohy V K, Tuthill R, Ransohoff R M. Central nervous system chemokine gene expression follows leukocyte entry in acute murine experimental autoimmune encephalomyelitis. Brain Behav Immun 1995b; 9: 315–330
  • Glabinski A, Tani M, Strieter R, Tuohy V, Ransohoff R. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of experimental autoimmune encephalomyelitis. Am J Pathol 1997; 150: 617–630
  • Glabinski A R, Tani M, Balasingam V, Yong V W, Ransohoff R M. Chemokine monocyte chemoattractant protein-1 (MCP-1) is expressed by astrocytes after mechanical injury to the brain. J Immunol 1996; 156: 4363–4368
  • Goes N, Sims T, Urmson T, Vincent D, Ramassar V, Holloran P. Disrupted MHC regulation in the IFN-gamma knockout mouse. Evidence for three states of MHC expression with distinct roles for IFN-gamma. J Immunol 1995; 155: 4559–4566
  • Gourmala N G, Buttini M, Limonta S, Sauter A, Boddeke H W. Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration. J Neuroimmunol 1997; 74: 35–44
  • Hartung H, Schafer B, van der Meide P, Fierz W, Heininger K, Toyka K. The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous svstem. Ann Neurol 1990; 27: 247–257
  • Hofman F, von Hanwehr R, Dinarello C, Mizel S, Hinton D, Merrill J. Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J Immunol 1986; 136: 3239–3247
  • Hofman F M, Hinton D R, Johnson K, Merrill J E. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989; 170: 607–612
  • Horwitz M, Evans C, McGavern D, Rodriguez M, Oldstone M. Primary demyelination in transgenic mice expressing interferon-gamma. Nature Med 1997; 3: 1037–1041
  • Karpus W J, Lukacs N W, McRae B L, Strieter R M, Kunkel S L, Miller S D. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 1995; 155: 5003–5010
  • Kim J S, Gautam S C, Chopp M, Zaloga C, Jones M L, Ward P A, Welch K M A. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J Neumimmunol 1995; 56: 127–134
  • Krakowski M, Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 1996; 26: 1641–1646
  • Merrill J, Kono D, Clayton J, Ando D, Hinton D, Hofman F. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci USA 1992; 89: 574–578
  • Narumi S, Wyner L, Stoler M, Tannenbaum C, Hamilton T. Tissue specific expression of murine IP-10 mRNA following systemic treatment with interferon-γ. J Leukocyte Biol 1992; 52: 27–33
  • Ohmori Y, Hamilton T A. IFN-gamma selectivity inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages. J Immunol 1994; 153: 2204–2212
  • Panitch H S, Hirsch R L, Haley A S, Johnson K P. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987a; 1: 893–895
  • Panitch H S, Hirsch R L, Schindler J, Johnson K P. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987b; 37: 1097–1102
  • Ping D, Jones P L, Boss J M. TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the MCP-1/JE gene. Immunity 1996; 4: 455–469
  • Ransohoff R, Tani M, Glabinski A, Chernosky A, Krivacic K, Peterson J, Chien H, Trapp B. Chemokines and chemokine receptors in model neurological pathologies: molecular and immunocyto-chemical approaches. Methods Enzymol 1997; 287: 319–348
  • Ransohoff R M, Hamilton T A, Tani M, Stoler M H, Shick H E, Major J A, Estes M L, Thomas D M, Tuohy V K. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 1993; 7: 592–602
  • Renno T, Krakowski M, Piccirillo C, Lin J Y, Owens T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J Immunol 1995; 154: 944–953
  • Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, Bussolino F, Poli V, Ciliberto G, Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315–325
  • Selmaj K, Raine C S, Canella B, Brosnan C F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991; 87: 949–954
  • Sethna M, Lampson L. Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. J Neuroimmunol 1991; 34: 121–132
  • Sharief M, Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 1991; 325: 467–471
  • Simmons R D, Willenborg D O. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J Neuro Sci 1990; 100: 37–42
  • Tani M, Glabinski A R, Tuohy V K, Stoler M H, Estes M L, Ransohoff R M. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am J Pathol 1996; 148: 889–896
  • Voorthuis J, Uitdehaag B, De Groot C, Goede P, van der Meide P, Dijkstra C. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin Exp Immunol 1990; 81: 183–188
  • Wojcik W J, Swoveland P, Zhang X, Vanguri P. Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of Lewis rat. J Pharmacol Exp Ther 1996; 278: 404–410
  • Zhou L, Miller R. Antibody-mediated oligodendrocyte cell death requires an astrocytederived cosignal. J Neurosci Res 1998; 52: 137–148

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.